We investigated the biological signi®cance of estrogen receptors (ER) in NIH3T3 cell transformation by the [ 12 Val] K-Ras mutant. This mutant enhanced the steady state level of ER. Cells expressing mutant K-Ras (K12V cell) were tumorigenic. To determine the role of ER accumulation in Ras-transformed cells, we developed cells (KwtER cells) that overexpressed both wild-type (wt) K-Ras and ER, and found these cells were also tumorigenic. E 2 stimulated the transcriptional activity by ER dominantly in K12V cells. However, only partial activation of ER by E 2 was seen in KwtER cells. In the presence of 10% serum in media, the activation of ER appeared only in transformed KtwER and K12V cells, suggesting that two independently transmitted signals, the E 2 -ER binding and the ER-AF1 activation, are necessary for ER activation and that the dominant activation of ER might be involved in Ras-mediated cell transformation. Co-expression of progesterone receptor (PR) with mutant K-Ras led to suppression of tumorigenicity and inhibition of the activation of ER. The antisense oligomers complementary to the ER suppressed proliferation and transformed phenotypes of K12V cells. These observations support the importance of ER in Ras-mediated cell transformation.
Introduction
Ras is an essential component in the transduction of extracellular signals. Considerable evidence now implicates Ras protein as a critical relay switch that controls signaling pathways connecting the cell surface with the nucleus. Ras protein is activated by growth factors, such as EGF, insulin and IGF. It then triggers the activation of a cascade of serine/threonine kinases, which includes Raf-1 and MAPK (mitogenactivated protein kinases) (Vojek et al., 1993; Warne et al., 1993; Zhang et al., 1993) . Activated MAPK then translocates to the nucleus where it phosphorylates and activates transcription factors which, in turn, cause changes in gene expression responsible for growth stimulation. Mutations that activate the Rastransforming potential result in mutant proteins that are unresponsive to the stimulation by GTPase activating proteins (Trahey and McCormick, 1987) . Consequently, mutant Ras persists in an active, GTPbound state, leading to constitutive and deregulated stimulation of growth regulatory processes that contributes to the aberrant growth properties of tumor cells. Mutations of H-, K-and N-ras genes have been noted in various types of precancerous lesions and cancers (Barbacid, 1987) . Studies on premalignant rat mammary glands suggest that mutated ras genes remain latent in this lesion and that additional factors are needed to trigger cancer development (Kumar et al., 1990) . However, molecular mechanisms involved in the transition from a precancerous lesion to cancer remains to be explained.
Estrogen (E 2 ) is also a potent mitogen. The E 2 signal is transmitted to the nucleus by binding with the estrogen receptor (ER). The dimerized E 2 -ER complex tightly binds to estrogen-responsive DNA sequences (ERE) acting as a transcription factor that can regulate gene expression, a phenomenon which depends on the presence of E 2 . E 2 has an important role in both the etiology and treatment of hormone dependent, breast and endometrial cancers. Cancers which have developed in nonovariectomized women often regress following E 2 removal or with treatment with the antiestrogen tamoxifen (Coezy et al., 1982) . Moreover, it is suggested that a mutation, a deletion or alternative splicing (resulting in deletions of ER exons 3, 4, 5, or 7) is frequently observed in breast cancer. The event causes deregulation of signals transmitted by E 2 or ER and, in turn, is linked to the development of hormone independent cancer (Petrangeli et al., 1994) . A recent study demonstrated the functional activation of ER through ER-AF1 by MAPK (Kato et al., 1995) . Therefore, the E 2 /ER binding eect is somehow modi®ed by the signal transduction cascade, though it remains unclear whether or not ER function is aected by deregulated signals from the activated Ras mutant.
We investigated the manner in which an activated mutant of Ras protein, in conjunction with E 2 -induced cell proliferation, facilitates initiation of tumors. We found that the dominantly activated [ 12 Val] K-Ras 4B mutant (mutant K-Ras) enhanced the steady state level of ER that functioned as a transcription factor in NIH3T3 cells. The importance of increased levels of ER protein in cell transformation was supported by the ®nding that the overexpression of both wild-type KRas and ER transformed NIH3T3 cells. Both activation of ER-AF1 and AF2 by stimulating the Ras-Raf-MAPK cascade and ligand binding caused dominant activation of ER function only in the transformed NIH3T3 cells. In turn, co-expression of PR and mutant K-Ras resulted in suppression of tumorigenic potentials. This eect of PR correlated with suppression of transcriptional activity by ER. In addition, the antisense oligomers complementary to the ER suppressed proliferation and transformed pheno-types of K12V cells. These ®ndings would help clarify the molecular mechanisms involved in the early stages of Ras-mediated cancer development. Figure 1A-c) . We also detected a larger band in K12V cells ( Figure 1A -e. It was likely that this band was endogenous mouse ER RNA induced in K12V cells. Therefore, to con®rm whether or not the mutant K-Ras aected the expression level of endogenous ER, we determined the steady state levels of ER proteins in these cells by Western blots using an ER monoclonal antibody. Low levels of ER were expressed in parent NIH3T3 cells, mock cells and in Kwt cells ( Figure 1B-a,b,d ). In comparison, the approximately a 2.5-fold increase of ER levels was observed in K12V cells. This protein level of ER was almost equal that in ER cells expressing exogenous human ER. (Figure 1B-c,e) . In contrast, mitogen-activated protein kinase (MAPK) levels remained essentially unchanged in all these cell lines ( Figure 1C ). The increase in ER levels in K12V cells appeared to correlate with the existence of mutant K-Ras ( Figure 1D Figure 1B-f,g ), although the dierence was smaller than that in NIH3T3 cell series.
Results

ER
Coordinated action by overexpressed ER in conjunction with wild-type K-Ras transforms NIH3T3 cells K12V cells exhibited an altered cellular morphology, and formed colonies in soft agar and palpable tumors in nude mice (Table 1) . To evaluate the biological signi®cance of overexpressed ER for Ras transformation, we established a cell-line co-expressing both wt K- Figure 2A) . Two of the three KwtER clones (C2 and C5) showed marked alterations in cell morphology ( Figure 2B) ; the cells were small, grew densely, and had a tendency to grow rapidly in a low serum medium (1% serum). These alterations were similar to those observed in K12V cells. Shortened population doubling and the potential to form colonies in soft agar cultures were noted in these two KwtER cell clones. To con®rm the transforming potentials in KwtER cells, we further isolated the additional three KwtER cell clones (KwtER C1, C3 and C6) from the pooled cells. As expected, two of the three (C3 and C6) showed in vitro transformed phenotypes. In addition, transplantation of 5610 6 cells from representative KwtER C2 and C5 clones produced palpable tumors in nude mice within 21 days. In contrast, individually overexpressed ER or wt K-Ras did not cause transformation of NIH3T3 cells. This means that the overexpressed ER rendered the NIH3T3 cells tumorigenic by co-operating with overexpressed wtK-Ras (Table 1 ). The two remaining clones (C1 and C4) did not carry transformed phenotypes for some undetermined reasons.
Ras-mediated signals enhance ER activity as a transcription factor
To investigate how K-Ras modulates the ER-mediated transcription through particular DNA sequences, we transiently transfected mock cells, Kwt cells, K12V cells, ER cells and KwtER cells with the pCATenhancer vector which contained an SV40 enhancer element and the vitellogenin A2 estrogen responsible I-Goat anti-mouse antibody and analysed using a Bio-ImageAnalyzer (Bas1000). ER protein was undetectable in mock cells (mock). In turn, abundant ER protein was detected in K12V cells (K12V). ER protein levels in three KwtER cell clones (C2, C4 and C5) are shown in the upper panel. The levels were similar among three KwtER cell clones. ER protein was encoded from endogenous ER in K12V cells whereas the protein was encoded from transfected human ER cDNA in three KwtER cells clones. MAPK levels that were determined by Western blots are shown in the middle. MAPK levels were constant amount mock, K12V and KwtER C2, C4 and C5 clones. P42 denoted p42 MAPK /ERK2. Ras protein levels expressed in these cells are shown below. Ras protein was immunoprecipitated from each cell lysate using Y-13 259 rat anti-Ras monoclonal antibody. Figure 3A) . The CAT activity stimulated by E 2 did not signi®cantly dier among each KwtER cell clone. This indicated that ER expressed from each cell functioned as a transcription factor dependent on E 2 stimulation. The most marked stimulation of CAT activity was seen in K12V cells. However, it remains uncertain whether steady state levels of ER aect the degree of transcriptional activation by ER. To clarify the correlation between ER transcriptional activity and ER protein level, we selected two kinds of subclones with dierent levels of ER protein (K12VC1 and C2), and the relative CAT activity by E 2 stimulation compared to that in mock cells was investigated. Although endogenous wt Ras proteins were expressed equivalently in these two clones, the levels of both ER protein and exogenous mutant K-Ras protein in K12VC1 were approximately twofold higher than those in K12VC2 ( Figure 3B ). The relative CAT activity, which was twofold higher in K12VC1 than The association between increased steady state levels of ER and its functional activation. Two representative K12V clones (C1 and C2) were selected from K12V pooled cells for the analysis. CAT assay was performed in the presence of E 2 (left). Transactivation is shown as a fold induction compared with that in mock cells. The value is the means obtained from three independent experiments. The ER protein level was approximately twofold higher in K12V C1 than that in K12V C2 clone (right upper). This increase was apparently associated with the high expression level of exogenous [ 12 Val] K-Ras mutant protein (right lower). Almost a twofold stimulation of CAT activity by E 2 (left) was seen in K12V C1, compared to that in K12V C2, suggesting the ER activity depended on its steady state level. ER levels were determined by Western blots and Ras protein expression was tested by immunoprecipitation. (a) mock cells, (b) a K12V C1 clone, (c) a K12V C2 clone that in K12VC2, correlated well with the protein levels of exogenous mutant K-Ras and ER. These observations suggest that the increased steady state level of ER induced by mutant K-Ras was responsible for the activation.
However, the transcriptional activity of ER by E 2 stimulation was less marked in ER and KwtER cells, even if the ER steady state level was high. Various growth factors activate the Ras-Raf-MAPK cascade, resulting in MAPK phosphorylating the transcriptional activation domain AF1 of ER (Kato et al., 1995; Bunone et al., 1996) . We hypothesized that insucient stimulation of ER AF1 was responsible for the lesser stimulation of ER activity in ER and KwtER cells, as the CAT assay was examined under conditions of low serum. In turn, transformation assay for K12V and KwtER was carried out in the presence of 10% calf serum. Thus, we examined the eect on CAT activity of calf serum, which showed the total eect of various growth factors and steroid hormones contained in the media. In the presence of 10% calf serum, enhanced ER activities were evident only in the transformed K12V and KwtER cells (Figure 4) .
PR suppresses NIH3T3 cell transformation mediated by the activated K-Ras mutant
The present study shows the possible involvement of ER activation in NIH3T3 cell transformation. Although ER and PR are members of dierent steroid hormone receptor subfamilies and recognize distinct hormone response elements, they may be in competition with each other for enhancer function (Meyer et al., 1989) . Both PR-A and -B isoforms act as potent ligand-dependent repressors of ER activity. Therefore, we utilized PR as a repressor of ER function to recon®rm the importance of ER activity in NIH3T3 cell transformation. We established NIH3T3 cell clones that expressed both the activated [ The steady state level of PR was high in K12VPRC3, but lower levels were detected in K12VPRC1 and C2 ( Figure 5A ). PR expression in K12VPRC3 revertd to the morphology of large and¯at cell types, being similar to that of the parent NIH3T3 and mock V cells ( Figure 2B ). This contrasts with the cell morphology in K12VPRC1 and C2, which was similar to that in transformed K12V cells. Thus, alteration in cell morphology probably depends on the level of PR expression. The inhibitory actions by PR were also demonstrated for colony-forming eciency and tumorforming ability of K12V cells (Table 1 ). The rate of soft agar colony formation was suppressed in K12VPRC3 by one tenth that in K12V cells. The latency period for palpable tumor formation was markedly prolonged when the K12VPRC3 cell was inoculated. Size of the tumors developed after 3 weeks of K12VPRC3 cell inoculation was also dominantly reduced. In contrast, the suppression was less marked in K12VPRC1 and C2. These ®ndings support with the assumption that a high level of PR expression has the potential to suppress cell transformation mediated by mutant K-Ras.
Our ®ndings suggest that functional activation of ER plays an important role in cell transformation. Thus, it is necessary to determine whether or not the inhibitory action of PR on cell transformation correlates with suppression of ER-mediated transcriptional activity. We investigated the E 2 -dependent transcriptional activation in K12VPR cells, using pCAT-enhancer vectors. The dierence in ER and Ras protein levels was not signi®cant among K12V cells and K12VPR C1 and C3 cells ( Figure 5A ) E 2 showed a 1.5-(K12VPRC3) or fourfold (K12VPRC1) increase in the CAT activity ( Figure 5B ), these demonstrating the less marked E 2 -dependent CAT activation in K12VPR cells. This ®nding is in sharp contrast to the 50-fold increase of the CAT activity in K12V cells. Progesterone was not required for this inhibitory eect by PR since media used for the CAT assay did not contain progesterone. However, a high concentration of progesterone (10 76 M) further suppressed the weak CAT activity (data not shown). Transcriptional activity by ER in K12VPR cells was also suppressed in the presence of normal calf serum ( Figure 5B ). Thus, we conclude that PR has suppressive eects on the cell transformation mediated by the mutant K-Ras. This eect of PR correlated with the inhibition of transcriptional activity of ER.
Antisenseoligomers targeted to ER inhibit cell growth and colony formation of K12V cells
It seemed that suppressive eects on cell transformation re¯ect a multitude of transcriptional eects of PR. Thus, we adopted a more direct means of testing the biological role of ER expression in cell transformation mediated by mutant K-Ras. The antisense oligomers had the sequence complementary to the ER transcriptional start site containing Kozak sequences. The level of ER protein was signi®cantly suppressed by treatment of 10 mM antisense oligomers with a 2 day incubation ( Figure 6A ). This eect of antisense oligomers seemed to be speci®c to ER as the MAPK levels were analogous among nontreated, nonsense oligomers-treated and antisense oligomer-treated K12V cells. Eects of the 10 mM oligomers on K12V cell growth were determined by monitoring the cell numbers over a four day period. A 4 day exposure of K12V cells to antisense oligomers reduced the cell number (61%) compared to that of non-exposed cells ( Figure 6B ). We observed no signi®cant reduction in the cell number of mock cells after the exposure to antisenseoligomers. Microscopic observations showed that K12V cells became large and sparse in the presence of antisense oligomers ( Figure 6B ). In contrast, no signi®cant dierence was recognized in the cell number and morphology of K12V cells after the exposure to nonsense oligomers. Likewise, the antisense oligomers caused a suppression of colony formation in K12V cells by the control (Figure 6C ). The rate of inhibition was 42% with 2 week-cultures ( Figure 6D ). In addition, the size of colonies formed was signi®cantly smaller in K12V cells exposed to the antisense oligomers than that in the non-exposed control cells. No signi®cant suppression of colony formation was observed for the nonsense oligomerstreated K12V cells (Figure 6C,D) . Thus, these results were compatible with the idea that the antisense oligomers exhibited suppressive eects on proliferation and transformed phenotypes of K12V cells. This eect may result from inhibiting ER expression levels. These observations would indicate that ER have a signi®cant role in Ras-mediated NIH3T3 cell transformation.
Discussion
ER contributes to NIH3T3 cell transformation
We obtained evidence that mutant K-Ras aected ER expression in NIH3T3 cells. The ®nding that the steady state level of ER was dependent on the K-Ras mutant level in K12V C1 and C2 suggests the presence of transcriptional and translational regulations of ER by the activated K-Ras mutant. To determine whether or not this increased ER protein contributed to mutant KRas mediated cell transformation, we established NIH3T3 cells that overexpressed both wt K-Ras and ER. Coexpression of these proteins caused cell transformation, whereas the overexpression of individual wt K-Ras or ER failed to transform cells. These observations suggest the importance of ER protein accumulation in cell transformation. K-Ras mutant results in constitutive accumulation of an active, GTPbound form. Overexpressed wt K-Ras also accumulates this active form in response to growth factors involved in the media and transmits growth-promoting stimuli to the downstream targets. This enhanced Rasmediated signal may interact with the abundant coexisting ER. The requirement of abundant ER protein for cell transformation implies that it has a critical function in triggering aberrant growth of cells.
Since ER functions as a transcription factor, we examined CAT activity in these reconstituted cells. E 2 stimulated the CAT activity dominantly in K12V cells, thereby exhibiting the potential of ER as a transcription factor. The level of transcriptional activation by ER in K12V cells was 2.5-fold higher than that in Kwt cells, in which a low level of ER protein was detected. Thus, activation of ER caused by E 2 in K12V cells probably derives from a higher steady state level of ER. However, E 2 stimulated CAT activity in transformed KwtER cells at a level similar to that seen in non-transformed Kwt or ER cells. ER has two transcriptional activation domains, AF1 and AF2, which are located in the NH2-terminal A/B region and in the ligand-binding region E, respectively (Kumar et al., 1987) . The signal through membraneassociated receptor tyrosine kinase-Ras-Raf-MAPK enhances the activity of ER-AF1 by stimulating phosphorylation of the serine residue at codon 118 (Kato et al., 1995) . We thus considered that functional activation of ER may require activation of both AF1 and AF2 and that the activation may be modulated by independently transmitted signals, those through the Ras-mediated cascade and classical E 2 pathway. We assumed that signals transmitted through the Ras-MAP kinase cascade are insucient in KwtER cells to activate ER since the CAT assay was examined in the absence of sucient growth factors. In contrast, the activated K-Ras mutant does not function as a biological switch between active, GTP-bound and inactive, GDP-bound states leading to a constitutive stimulation of downstream targets. This acquired function mutation is able to overcome the growth factor requirement for funcational activation of ER. In the present study, the transforming potential of the reconstituted NIH3T3 cells was examined in the presence of normal calf serum, which contained various growth factors and steroid hormones. Thus, we examined the eect of calf serum on the CAT activity. Stimulation of the CAT activity by serum was demonstrated in both transformed K12V and Kwt ER cells, thus indicating the importance of overexpressed ER followed by functional activation for NIH3T3 cell transformation, when co-existing with enhanced Rasmediated signals. ER steady state levels are too low to trigger its dominant activation in nontransformed Kwt cells. In turn, the Ras-mediated signals are insucient to activate ER functions in ER cells. Taken together, the present data suggest that the oncogenic eect by mutant K-Ras is exhibited when ER function is simultaneously activated. Previous observations using neonatal rats exposed to the carcinogen support the view that ER contributes to cell transformation mediated by mutant Ras (Kumar 1990 ). The activated ras oncogene can remain latent within the mammary gland until exposure to E 2 . Maturation of the normal endocrine system in target organs, such as E 2 -induced mammary gland development, can lead to neoplasia if ER levels following exposure to antisense oligomers in K12V cells. Mock cells and K12V cells were exposed to 10 mM antisense oligomers targeted to ER or nonsense oligomers for 2 days and cells were lysed. Western blot was performed as described under Materials and methods. The level of ER protein in K12V cells was reduced signi®cantly by exposure to 10 mM antisense oligomers but not by exposure to nonsense oligomers. However, reduction of ER levels by exposure to 10 mM antisense oligomers was unclear in mock cells because the levels were extremely low. This eect of antisense oligomes seemed to be speci®c to ER because the oligomers did not aect MAPK levels (lower). NS: nonsense, AS: antisense. (B) Growth suppression of K12V cells due to exposure to antisense oligomers. Mock cells and K12V cells were plated at 2.0610 4 cells per 24 well plates. Antisense oligomers or nonsense oligomers were added to the medium the next day (day 0) and on day 2. The number of viable cells was counted on days 2 and 4. The exposure to antisense oligomers resulted in the suppression of K12V cell growth (right). In contrast, antisense oligomers did not suppress mock cell growth (left). Nonsense oligomers did not suppress mock or K12V cell growth. (C) Alterations in cell morphology and colony size in K12V cells exposed to antisense oligomers. Antisense oligomers altered the shape and size of K12V cells (a). K12V cells exposed to antisense oligomers increased in size and grew sparsely (magni®cation660). Anchorage-independent growth assays in the presence or absence of antisense oligomers (10 mM) were performed as described under Materials and methods. Antisense oligomers signi®cantly reduced the colony size formed in soft agar cultures of K12V cells (b). However, nonsense oligomers exhibited no suppressive eects. (D) Decreased colony forming eciency in antisense oligomer treated K12V cells. Colony forming eciency was signi®cantly suppressed by antisense oligomers targeted to ER. Colony forming eciency was suppressed in K12V cells exposed to antisense oligomers to almost one half of that of non-treated or nonsense oligomer-treated K12V cells. (C and D); 7: non-treated, NS: nonsense oligomer-treated, AS: antisense oligomer-treated K12V cells target cells harbor latent ras mutants. In the absence of sexual development, the activated ras is unable to induce cell transformation in these glands. This supports the idea that the activated Ras mutant by itself is insucient to facilitate cell transformation and requires enhanced ER function. It seems likely that Ras proteins regulate multiple and/or branching signal transduction pathways. The Ras-ER pathway may be involved in these multiple Ras-mediated signal transduction pathways. Each distinct pathway may be associated with various transformed cell properties that implies in vitro cell growth, anchorage independent growth and tumorigenicity in nude mice. However, it remains unclear how much the Ras-ER signal transduction pathway contributes to NIH3T3 cell transformation mediated by the mutant K-Ras.
Recently, several estrogen-inducible genes containing the ERE region have been reported. Among them, lactoferrin, which has been overexpressed in human endometrial cancers, is one of the major E 2 -inducible proteins (Walmer et al., 1995) . In addition, another type of estrogen-responsive gene that encodes a RING ®nger protein has been isolated (Inoue et al., 1993) . The RING ®nger protein belongs to a family of apparent DNA-binding proteins. Some nuclear oncogenes, such as c-myc and c-jun, are involved in these estrogen-responsive genes. Thus, we propose that functional activation of ER, mediated by mutant KRas, would contribute to NIH3T3 cell transformation through ampli®cation of downstream target gene activity. In response to E 2 , induction of each c-myc and c-jun gene product in ER-positive breast cancer cell lines and in the rat uterus supports this proposal (Dubik et al., 1987; Cicatiello et al., 1992) . Further investigations focusing on the interaction between ER and its downstream targets will clarify the ER involvement in mutant K-Ras-mediated cell transformation.
Suppression of ER inhibits the transforming potentials of mutant K-Ras
Our ®ndings show the functional activation of ER by mutant K-Ras. Since ER and PR act on target cells by regulating the expression of a wide variety of signaling molecules, both receptors compete for factors that mediate their enhancer function (Meyer et al., 1989) . Our ®nding demonstrates that constitutive PR expression suppresses partially transformed phenotypes of K12V cells. The degree of this suppression correlated with the protein levels of PR in K12V cells. The suppressive eect was the most evident in the K12VPRC3, which expressed PR protein abundantly. Inhibition of the transactivation by ER correlated with this suppressive eect of PR. These results conversely suggest the importance of the functional activation of ER in cell transformation mediated by mutant K-Ras. This is further supported by evidence that antisense oligomers complementary to the ER transcriptional start site exhibited suppressive eects on transformed phenotypes of K12V cells, by suppressing ER expression.
In the present study, we did not add progesterone to the medium of the CAT assay. This is dierent from other studies that demonstrated that the liganded PR could have potent inhibitory eects on various transcriptional activators (Kraus et al., 1995) . The vector used in the present experiment expresses PR-B, the dominant activator of progesterone-responsive target genes. PR-A functions to inhibit this activity as a modulator of PR-B. PR-B expression, in the absence of PR-A, would correspond to the unnecessary use of progesterone. Alternatively, the inhibitory action of PR would require the binding with a very small amount of ligand contained in the 1% charcoal-dextran treated calf serum. While further study on other human carcinoma cell-lines is necessary, our ®ndings support the proposal that PR has an inhibitory eect on mutant K-Ras-mediated cell transformation by interfering with the transcriptional activity of ER.
Materials and methods
Plasmids pZIP-Neo SV(X)1 retrovirus vector and constructs containing cDNA sequences encoding either wild-type KRas4B or [
12 Val]K-Ras4B were gifts from Dr Channing J Der (University of North Carolina). As characterized previously (Kato et al., 1992) 12 Val]K-Ras4B and empty pSG5 vector using lipofectoamine (BRL). Stably transfected cells were selected and isolated in growth medium containing 400 mg/ml G418 (Geneticin; GIBCO) to establish cell lines expressing each Ras protein. Ras protein expression was con®rmed by immunoprecipitation, using the Y13-259 rat anti-Ras monoclonal antibody (Oncogene Science). NIH3T3 cells harboring ER or PR were established the same way as above by co-transfection with pSG5-human ER or -human PR-B cDNA and empty pZIP-NeoSV(X)1 retrovirus vector constructs. All cell lines were maintained in Dulbecco's modi®ed Eagle's medium (DMEM) (Nissui Seika) supplemented with 10% calf serum (Sigma).
Western blots
For detection of ER or PR or MAPK proteins, cells were lysed by three cycles of freeze-thaw (7808C/48C) in 1% NP40 and 20 mM Tris-HCl pH 7.5, and centrifuged at 13 000 g for 20 min at 48C to remove debris (Ali et al., 1993) . Protein concentrations were determined using Coomassie Protein Assay (PIERCE) and 100 mg was loaded on a 10% SDS-polyacrylamide gel and transferred to nitrocellulose in a semi-dry transfer Cell (Bio Rad). The blot was incubated with the ER monoclonal antibody (AER 304: NeoMarkers) or the PR monoclonal antibody (IOPATH) or the MAPK monoclonal antibody (SEIKAGAKU Corporation) followed by incubation with 125 I-Goat anti-mouse antibody (Amersham). The amount of proteins was quantitated using a Bio-image analyzer (BAS1000, FUJIX, Japan).
Northern blot analysis
Extraction of total RNA from cells was done by guanidium-isocyanate/CsCl gradient centrifugation. Total RNA (10 mg) was run on a 1.5% agarose gel, transferred to a nylon ®lter (HYBOND N + , Amersham) and hybridized with a 32 P-labeled human ER cDNA probe or human GAPDH cDNA probe in a hybridization buer (56SSC, 56Denhardt, 100 mg/ml Salmon sperm, 50% formamide, 0.1% SDS) at 428C. The blot was washed in 56SSC/0.1% SDS at room temperature and 16SSC at 428C and analysed using a Bio-image analyzer (BAS1000, FUJIX, Japan).
CAT assay
Vitellogenin A2 ERE (5'-GATCTAGGTCACAGTGACC-TA-3') was inserted into the pCAT-Enhancer Vector which contains an SV40 enhancer element (Promega). Each cell was transfected with the pCAT vector only, pCAT vector containing vitellogenin A2 ERE and pSV-b-galactosidase control plasmid (Promega). After transfection (16 h), the cells were incubated for 72 h with phenol-red-free DMEM containing 10% charcoal-dextran-treated calf serum. The medium was then replaced overnight with phenol-red free DMEM containing 1% charcoal-dextran-treated calf serum in the presence or absence of 10 77 M 17b-estradiol (Sigma). After washing in phosphate buer saline, the cells were suspended in 0.25 M Tris-Cl, pH7.8 and lysed by ®ve cycles of freeze-thaw. Protein concentrations were determined and CAT assay of 10 mg cell extract was performed as described (Ignar-Trowbridge et al., 1993) . Transfection eciency was normalized by b-galactosidase assays (Promega).
Assay of tumorigenicity
For the anchorage-independent growth assay, 10 4 cells were seeded in growth medium, supplemented with 10% calf serum and 0.3% Bactoagar over a hardened 0.5% agar base layer in 60 mm dishes. After 18 days, colonies were counted in triplicate. For tumor growth assay in nude mice, 10 6 cells per site were inoculated to nude mice. After 21 days, tumor size and numbers were evaluated.
Antisense study
Two kinds of the phosphorothioate oligomers were purchased from Greiner Japan, 21-mer antisense oligonucleotides complementary to the ER transcriptional start site, including Kozak sequences (5'-GTGAAGGGT-CATGGTCATGGT-3') and 21-mer nonsense oligonucleotides containing the same numbers of each nucleotide as antisense oligomer (5'-GAGGTCACGGGAGATTGT-TGT-3'). To con®rm the eect of the antisense oligomers on ER expression, mock cells and K12V cells were exposed to 10 mM of each oligomer for 2 days and lysed. Western blot was performed as described above. To determine the eect of oligomers on growth rates, mock cells and K12V cells were plated at 2.0610 4 cells per 2.0 mm 2 24 well plates (Falcon) in DMEM supplemented with 10%CS and incubated overnight. Antisense oligomers or nonsense oligomers (10 mM) were added to the medium the next day (day 0) and on day 2. The number of viable cells was counted on days 2 and 4. For the anchorage-independent growth assay, 10 4 K12V cells were seeded in growth medium supplemented with 10% calf serum and 0.3% Bactoagar (with or without oligomers) over a hardened 0.5% agar base layer in 60 mm-dish. After 14 days, colonies were counted in triplicate. Cells that were exposed to oligomers were prestimulated with 10 mM oligomer for the preceding 2 days before seeding.
